The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.

[1]  Stephen T Holgate,et al.  Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.

[2]  A. Togias,et al.  Omalizumab-induced reductions in mast cell FcεRI expression and function , 2004 .

[3]  E. Chilvers,et al.  Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate‐to‐severe) allergic asthma , 2004, Allergy.

[4]  L. Boulet,et al.  Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR , 2004, Allergy.

[5]  J. Bousquet,et al.  Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  J. Bousquet,et al.  Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. , 2004, Chest.

[7]  T. Casale,et al.  Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils , 2004 .

[8]  T. Casale,et al.  Omalizumab treatment downregulates dendritic cell FcεRI expression , 2003 .

[9]  D. Metcalfe,et al.  Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. , 2003, The Journal of allergy and clinical immunology.

[10]  Toshiaki Kawakami,et al.  Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Jackson,et al.  Allergen sensitization and bronchial hyper‐responsiveness to adenosine monophosphate in asthmatic patients , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  D. Postma,et al.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.

[13]  T. Casale,et al.  Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  O. Noga,et al.  Immunological and Clinical Changes in Allergic Asthmatics following Treatment with Omalizumab , 2003, International Archives of Allergy and Immunology.

[15]  U. Wahn,et al.  Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season. , 2003, The Journal of allergy and clinical immunology.

[16]  T. Casale,et al.  Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. , 2003, The Journal of allergy and clinical immunology.

[17]  Toshiaki Kawakami,et al.  Regulation of mast-cell and basophil function and survival by IgE , 2002, Nature Reviews Immunology.

[18]  T. Sandström,et al.  The effect of omalizumab on nasal allergic inflammation. , 2002, The Journal of allergy and clinical immunology.

[19]  D. Botstein,et al.  Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11 , 2002, BMC Immunology.

[20]  T. Casale,et al.  Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. , 2001, JAMA.

[21]  W. Busse,et al.  Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. , 2001, The Journal of allergy and clinical immunology.

[22]  R. Townley,et al.  The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. , 2001, The European respiratory journal.

[23]  H. Milgrom,et al.  Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). , 2001, Pediatrics.

[24]  A. B. Kay,et al.  Allergy and Allergic Diseases , 2001 .

[25]  A B Kay,et al.  Allergy and allergic diseases. Second of two parts. , 2001, The New England journal of medicine.

[26]  A B Kay,et al.  Allergy and allergic diseases. First of two parts. , 2001, The New England journal of medicine.

[27]  J. Bousquet,et al.  Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality* , 2001, Current medical research and opinion.

[28]  T. Haahtela,et al.  Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. , 2000, The Journal of allergy and clinical immunology.

[29]  S. Galli,et al.  The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. , 2000, The Journal of allergy and clinical immunology.

[30]  P. Sly,et al.  The role of allergy in the development of asthma , 1999, Nature.

[31]  L. Lichtenstein,et al.  Upregulation of FcϵRI on human basophils by IgE antibody is mediated by interaction of IgE with FcϵRI , 1999 .

[32]  L. Boulet,et al.  Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. , 1997, American journal of respiratory and critical care medicine.

[33]  H. Boushey,et al.  The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[34]  A. Togias,et al.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.

[35]  A. Togias,et al.  Serum IgE level drives basophil and mast cell IgE receptor display. , 1997, International archives of allergy and immunology.

[36]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[37]  F. Martinez,et al.  Association of asthma with serum IgE levels and skin-test reactivity to allergens. , 1989, The New England journal of medicine.